NCT04267679撤回2 期
Prospective Evaluation of Cannabidiol (CBD) on Anxiety: A Pilot Study
CB2 Insights0 个研究点开始时间: 2020年3月1日最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 撤回
- 发起方
- 主要终点
- Generalized Anxiety Disorder 7-item scale
研究概览
简要总结
This pilot trial seeks to investigate the effect of 25 mg full-spectrum CBD soft gel capsules (up to a total dosage of 100mg per day) on individuals with diagnosed anxiety. All participants will take CBD soft gel capsules for 12 weeks, and will be assessed at 6 weeks and 12 weeks post-enrollment using measures of anxiety, sleep and perception of change.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Cannabidiol
Experimental
Participants will take 25 mg full-spectrum CBD soft gel capsules (2 to 4 per day) for 12 weeks.
干预措施: Cannabidiol (Drug)
结局指标
主要结局
Generalized Anxiety Disorder 7-item scale
时间窗: 12 weeks
The Generalized Anxiety Disorder 7-item scale is one of the most frequently used, validated self-reported questionnaires that is used to screen for, diagnose, and assess severity of generalized anxiety disorder.
次要结局
- Perception of change(12 weeks)
- Protocol Compliance(12 weeks)
- Sleep quality(12 weeks)
研究者
相似试验
招募中
2 期
MIVetsCan: Cannabidiol (CBD)-Care TrialPain, ChronicNCT06213233Kevin Boehnke468
终止
3 期
Cannabidiol and Management of Endometriosis PainCBDPelvic PainEndometriosisNCT04527003Milton S. Hershey Medical Center12
已完成
2 期
Enhancing Medication-based Analgesia in Humans- STUDY 2PainCannabisOpioid UseNCT04036968Johns Hopkins University31
招募中
2 期
PAIN: a Project Assessing the Impact of a Novel Cannabinoid ProductChronic PainNCT03984565Staci Gruber, Ph.D.25
Unknown
2 期
CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate SymptomsSARS-CoV2NCT04467918University of Sao Paulo100